Hybridan Small Cap Wrap: Joint Venture to Monitise APAC business, Nasstar on a cloud and Poptastic! Dave Cash launches on One Media

Tuesday, May 03 2011 by
4
Hybridan Small Cap Wrap Joint Venture to Monitise APAC business Nasstar on a cloud and Poptastic Dave Cash launches on One Media

This week: Joint Venture to Monitise APAC business, Nasstar on a cloud and Poptastic! Dave Cash launches on One Media

African Eagle (LON:AFE) (AFE 11.8p/£48.1m)

African Eagle Resources, a mineral exploration and development company, has announced that it has executed a farm-in agreement with BrightStar Resources Ltd (BUT) over the Company’s Miyabi Gold Project in Tanzania, under the terms of which BUT will expend $3m in 30 months to earn 50 per cent. A minimum expenditure of $1m is required of BrightStar within the first 12 months. BrightStar can actually earn 75 per cent by sole funding and completing a feasibility study.

Angel Biotech (LON:ABH) (ABH 0.36p / £9.77m)*

AIM listed Angel last week commented on the announcement in the press regarding an ongoing European legal case concerning the patentability of human embryonic stem cells. A legal opinion has been given by the advocate-general of the European Court of Justice (ECJ) that patent claims involving human embryonic stem cells should not be allowed. The ECJ is due to decide over the coming months whether to uphold this legal opinion in their ruling on the case. Angel wishes to state that the majority of work currently ongoing at Angel, and the work that the Company is seeking to secure in the future, is based on the use of adult stem cells. Also many of the programs are autologous in nature where the patients' own cells are used for the clinical procedure. Neither of these technologies is affected by the EU opinion. Dr Paul Harper, Chairman of Angel, said: "We believe that the significant market opportunity for the cell therapy services we offer will be derived in North America and this will not be affected by this ruling." Angel recently secured a fifteen year lease, with an option to break after five years, on a GMP manufacturing facility in Cramlington, near Newcastle upon Tyne. The facility, which the Company knows well, will increase Angel's manufacturing capacity approximately five-fold when re-commissioned and will be unaffected by the issues discussed in the ongoing debate surrounding human embryonic stem cells in Europe. The Board expects the facility to be operational before the end of 2011. The market looks forward to further comment on how Angel progresses as it adds the extra capacity it needs.

Anglesey Mining (LON:AYM)…

Unlock this article instantly by logging into your account

Don’t have an account? Register for free and we’ll get out your way

Disclaimer:  

This document should not be relied upon as being an impartial or objective assessment of the subject matter and is not deemed to be "independent research" for the purposes of the Financial Services Authority (FSA) rules. As a consequence the research (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research; and (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research (although Hybridan does impose restrictions on personal account dealing in the run up to publishing research as set out in our Conflicts of Interest Policy).

The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual partners and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document.

This document has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments. The information contained herein is based on materials and sources that we believe to be reliable, however, Hybridan LLP makes no representation or warranty, either express or implied, in relation to the accuracy, completeness or reliability of the information contained herein. Opinions expressed are our current opinions as of the date appearing on this material only. Any opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. None of Hybridan LLP, its affiliates or employees shall have any liability whatsoever for any indirect or consequential loss or damage arising from any use of this document.

In the UK, this report is directed at and is for distribution only to persons who (i) fall within Article 19(1) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotions) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties of Hybridan LLP (all such persons together being referred to as "relevant persons"). This report must not be acted on or relied up on by persons in the UK who are not relevant persons.

Neither this report nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this report comes should inform themselves about, and observe any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Investments in general involve some degree of risk, including the risk of capital loss. The services, securities and investments discussed in this document may not be available to or suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and, if in any doubt, should seek advice from an investment advisor. Past performance is not necessarily a guide to future performance and an investor may not get back the amount originally invested. Where investment is made in currencies other than the investor?s base currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable. Levels and bases for taxation may change. When Hybridan LLP comments on AIM or PLUS Markets shares investors should be aware that because the rules for those markets are less demanding than the Official List of the London Stock Exchange the risks are higher. Furthermore, the marketability of these shares is often restricted.

Hybridan LLP and/or its associated companies may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the partners, directors and employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests. Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without the prior consent of Hybridan LLP. Hybridan LLP is Authorised and Regulated by the Financial Services Authority and is a member of the London Stock Exchange.


Hybridan LLP
29 Throgmorton Street, London EC2N 2AT

If you would like to receive other research reports from Hybridan, or would like to unsubscribe, please e- mail research@hybridan.com, title e-mail "research reports" or "unsubscribe me" Hybridan LLP is authorised and regulated by the Financial Services Authority Member of the London Stock Exchange


Do you like this Post?
Yes
No
4 thumbs up
0 thumbs down
Share this post with friends



Transense Technologies plc is engaged in the manufacture of electrical switchgear management systems. The Company's segments include SAWsense and Translogik. The SAWSense segment designs and develops surface acoustic wave (SAW) sensor devices that can be used to measure torque, pressure and/or temperature. This technology has a range of uses, ranging from custom applications through to high volume mass markets, such as passenger cars. The Translogik segment designs and manufactures a range of tire pressure monitoring systems (TPMS), products and services for heavy-duty off-road vehicles, commercial and passenger transport vehicles. These consists of the iTrack system, which provides real-time tire temperature and pressure measurements for mine-haul trucks in service, and a range of tire probes and other offerings for the road transport sector. The Company is also engaged in the development of non-contact batteryless sensors and their electronic interrogation systems. more »

LSE Price
71p
Change
 
Mkt Cap (£m)
11.6
P/E (fwd)
n/a
Yield (fwd)
n/a

Blue Star Capital Plc is a United Kingdom-based investment company. The Company is engaged in investing in assets or companies in various sectors, such as gaming, media and technology. The Company seeks investments in late-stage venture capital and early-stage private equity opportunities, which allows a diverse portfolio of investments within different sectors and geographic locations. The Company's geographical range is the United Kingdom companies but considers opportunities in the mainland European Union and co-invests in deals. The Company also holds investments in investee companies in other sectors. The Company takes positions in investee companies by way of equity, debt or convertible or hybrid securities. Cairn Financial Advisers LLP is the advisor of the Company. more »

LSE Price
0.104p
Change
 
Mkt Cap (£m)
2.1
P/E (fwd)
n/a
Yield (fwd)
n/a

Sigma Capital Group plc is a holding company. The Company, together with its subsidiaries, is a property group principally focused on encompassing urban regeneration and property asset management. The Company operates through three business segments: property, venture capital fund management, and holding company activities. The Company's subsidiaries include Sigma Inpartnership Limited (SIP), Strategic Property Asset Management Limited (SPAM) and Sigma Technology Investments Limited (STI). Its property regeneration activities are carried out by its subsidiary, SIP, which undertakes property-related regeneration projects, working as a bridge between public and private sector organizations. more »

LSE Price
101.5p
Change
 
Mkt Cap (£m)
90.8
P/E (fwd)
7.6
Yield (fwd)
2.3



  Is LON:TRT fundamentally strong or weak? Find out More »


Please subscribe to submit a comment




About Hybridan

Hybridan

Hybridan is a corporate broker and PLUS markets corporate advisor specialising in fundraising, research and after-market support for small and micro cap companies. We utilise our market knowledge to provide creative financing solutions and strong after-market support. We build long term durable relationships with companies and investors, for the benefit of both. This long term approach, coupled with a high degree of selectivity, yields investments that outperform the market. more »



Stock Picking Tutorial Centre



Let’s get you setup so you get the most out of our service
Done, Let's add some stocks
Brilliant - You've created a folio! Now let's add some stocks to it.

  • Apple (AAPL)

  • Shell (RDSA)

  • Twitter (TWTR)

  • Volkswagon AG (VOK)

  • McDonalds (MCD)

  • Vodafone (VOD)

  • Barratt Homes (BDEV)

  • Microsoft (MSFT)

  • Tesco (TSCO)
Save and show me my analysis